Tapewire

Nasdaq · USD

NTRA

Natera, Inc.

Export transactions ↓
Tapewire entity
2635
SEC CIK
0001604821
Parsed reports
1,197

Last 12 months

Inside the activity.

0 purchase rows · 457 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025047
Dec 2025021
Jan 2026041
Feb 2026021
Mar 2026054
Apr 2026029
May 2026033
Jun 2026068
Jul 2026047
Aug 2026033
Sep 2026059
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 687 $0.00 Strike: $45.88 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 18

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 687 shares

Expires 2033-07-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 607 $0.00 Strike: $51.40 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 17

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 607 shares

Expires 2033-04-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 793 $0.00 Strike: $41.82 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 16

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 793 shares

Expires 2033-01-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 851 $0.00 Strike: $41.51 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 15

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 851 shares

Expires 2032-10-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 884 $0.00 Strike: $40.48 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 14

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 884 shares

Expires 2032-07-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 14,136 $0.00 Strike: $41.19 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 13

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,136 shares

Expires 2032-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 735 $0.00 Strike: $42.86 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 12

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 735 shares

Expires 2032-04-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionStock Option (right to buy) · Derivative 424 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 11

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 424 shares

Expires 2032-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 807 $38.26 $30,875.82
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 9

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 687 $45.88 $31,519.56
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 8

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,469

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 607 $51.40 $31,199.80
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 7

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 793 $41.82 $33,163.26
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 6

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 851 $41.51 $35,325.01
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 5

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 884 $40.48 $35,784.32
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 4

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 14,136 $41.19 $582,261.84
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 3

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 735 $42.86 $31,502.10
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 2

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 16, 2024 01:05 UTC
BOTHA ROELOFDirector
Exercise / conversionCommon Stock 424 $67.37 $28,564.88
Disclosure

SEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 1

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 776

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 30, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 20,070 $89.60 $1,798,370.34
Disclosure

SEC source: 0001415889-24-009473 · form4-03292024_090304.xml · nonDerivative · entry 3

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Indirect · By Chapman Family Trust

Disclosed balance after: 0

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.4050 to $89.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 15, 2024 Filed Mar 30, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 20,575 $88.97 $1,830,574.21
Disclosure

SEC source: 0001415889-24-009473 · form4-03292024_090304.xml · nonDerivative · entry 2

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Indirect · By Chapman Family Trust

Disclosed balance after: 20,070

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.4050 to $89.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 15, 2024 Filed Mar 30, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 10,265 $87.98 $903,120.86
Disclosure

SEC source: 0001415889-24-009473 · form4-03292024_090304.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Indirect · By Chapman Family Trust

Disclosed balance after: 40,645

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.4050 to $88.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 50,910 shares previously reported as owned indirectly by the Rosewood Trust.

F4 · ownership.nature: The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 07, 2024 Filed Mar 9, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
GiftCommon Stock 55,427 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-007459 · form4-03082024_080301.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: No plan indicated

Ownership: Indirect · By Caraluna 2 Trust

Disclosed balance after: 70,082

F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
March 07, 2024 Filed Mar 9, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
GiftCommon Stock 55,427 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-007459 · form4-03082024_080301.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: No plan indicated

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 70,082

F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
March 07, 2024 Filed Mar 9, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
GiftCommon Stock 110,854 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-007459 · form4-03082024_080301.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 347,731

F1 · shares: The transaction represents a gift by the Reporting Person.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 02:40 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 1,816 $89.13 $161,856.81
Disclosure

SEC source: 0001415889-24-007247 · form4-03072024_090320.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 458,585

F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.03 to $89.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 02:40 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 3,184 $88.45 $281,635.31
Disclosure

SEC source: 0001415889-24-007247 · form4-03072024_090320.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 460,401

F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.99 to $88.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 1,823 $88.37 $161,089.40
Disclosure

SEC source: 0001415889-24-007242 · form4-03072024_090304.xml · nonDerivative · entry 3

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,663

F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 15 $87.37 $1,310.48
Disclosure

SEC source: 0001415889-24-007242 · form4-03072024_090304.xml · nonDerivative · entry 2

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,486

F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 2,227 $88.37 $196,788.86
Disclosure

SEC source: 0001415889-24-007243 · form4-03072024_090309.xml · nonDerivative · entry 3

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,267

F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 18 $87.33 $1,571.86
Disclosure

SEC source: 0001415889-24-007243 · form4-03072024_090309.xml · nonDerivative · entry 2

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,494

F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.31 to $87.3415 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 9,326 $88.37 $824,091.99
Disclosure

SEC source: 0001415889-24-007245 · form4-03072024_090316.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,957

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 2,826 $88.37 $249,719.49
Disclosure

SEC source: 0001415889-24-007244 · form4-03072024_090314.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,646

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 1,028 $88.37 $90,839.22
Disclosure

SEC source: 0001415889-24-007247 · form4-03072024_090320.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 463,585

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 2,160 $88.37 $190,868.40
Disclosure

SEC source: 0001415889-24-007246 · form4-03072024_090318.xml · nonDerivative · entry 1

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,218

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 5,492 $89.40 $491,004.02
Disclosure

SEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 6

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Indirect · By RMDM Trust

Disclosed balance after: 860,036

F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023.

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.15 to $89.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 13,743 $88.64 $1,218,237.24
Disclosure

SEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 5

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Indirect · By RMDM Trust

Disclosed balance after: 865,528

F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $89.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 96,977 $87.49 $8,484,963.82
Disclosure

SEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 4

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Indirect · By RMDM Trust

Disclosed balance after: 879,271

F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.15 to $88.10 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 73,788 $86.88 $6,410,863.77
Disclosure

SEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 3

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Indirect · By RMDM Trust

Disclosed balance after: 976,248

F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.15 to $87.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 1,004 $88.37 $88,718.46
Disclosure

SEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 2

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,075,648

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:40 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 8 $87.25 $698.00
Disclosure

SEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 1

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,076,652

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 01:45 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
GrantCommon Stock 2,400 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-006193 · form4-03012024_080301.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,894

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 01:45 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
GrantCommon Stock 2,329 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-006194 · form4-03012024_080304.xml · nonDerivative · entry 1

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,306

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 01:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
GrantCommon Stock 9,326 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-006196 · form4-03012024_080311.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,283

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 01:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
GrantCommon Stock 2,826 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-006195 · form4-03012024_080309.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,472

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 01:45 UTC
Sheena JonathanDirector · CO-FOUNDER
GrantCommon Stock 1,028 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 7

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 464,613

F10 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

F11 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 01:45 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
GrantCommon Stock 4,104 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-006198 · form4-03012024_080319.xml · nonDerivative · entry 1

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,076,660

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 01:45 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
GrantCommon Stock 2,160 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-006197 · form4-03012024_080313.xml · nonDerivative · entry 1

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,378

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 02:15 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 20,526 $0.00 Strike: $9.29 $0.00
Disclosure

SEC source: 0001415889-24-006005 · form4-02292024_090201.xml · derivative · entry 11

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,526 shares

Expires 2028-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 02:15 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 14,426 $89.72 $1,294,351.21
Disclosure

SEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 8

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,218

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.53 to $89.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 02:15 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 3,400 $87.87 $298,765.14
Disclosure

SEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 7

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 218,644

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.80 to $88.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 02:15 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 2,600 $86.67 $225,344.08
Disclosure

SEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 6

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,044

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.43 to $87.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.